 "Pfizer Q3 results: Net profit falls 2% to Rs 128 cr, revenue at Rs 538 cr")
Drug firm Pfizer on Friday said its net profit declined by 2 per cent to Rs 128 crore for the third quarter ended December 31, 2024.
The company had reported a net profit of Rs 130 crore in the October-December period of last fiscal.
Revenue from operations declined to Rs 538 crore in the third quarter as compared with Rs 540 crore in the year-ago period, Pfizer Ltd said in a regulatory filing.
Shares of the company on Friday ended 0.43 per cent up at Rs 4,536.05 apiece on BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app